Grant/GrossMendelsohn, LLC
- SEC CIK
- 0001810677
- Latest filing
- May 1, 2025
EW holding history
Edwards Lifesciences Corp in every 13F filed by Grant/GrossMendelsohn, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q1 2025 holdings
- Shares (Q1 2025)
- 7,623
- Value
- $575.8K
- % of portfolio
- 0.3%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 7,623 | $575.8K | 0.3% | −35−0.5% | Reduced | Holders |
| Q4 2024 | 7,658 | $566.9K | 0.3% | −200−2.5% | Reduced | Holders |
| Q3 2024 | 7,858 | $518.5K | 0.2% | −100−1.3% | Reduced | Holders |
| Q2 2024 | 7,958 | $735.1K | 0.3% | −100−1.2% | Reduced | Holders |
| Q1 2024 | 8,058 | $749.8K | 0.3% | −33−0.4% | Reduced | Holders |
| Q4 2023 | 8,091 | $592.6K | 0.2% | −350−4.1% | Reduced | Holders |
| Q3 2023 | 8,441 | $584.8K | 0.3% | −30−0.4% | Reduced | Holders |
| Q2 2023 | 8,471 | $783.1K | 0.3% | +8,471 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −8,740−100.0% | Sold out | Holders |
| Q4 2022 | 8,740 | $673.1K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 8,740 | $749.0K | 0.4% | −100−1.1% | Reduced | Holders |
| Q2 2022 | 8,840 | $851.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2022 | 8,840 | $1.10M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2021 | 8,840 | $1.08M | 0.9% | −100−1.1% | Reduced | Holders |
| Q3 2021 | 8,940 | $1.05M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2021 | 8,940 | $955.0K | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2021 | 8,940 | $853.0K | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.